ImmuCell Corporation (ICCC) CEO Michael Brigham on Q3 2018 Results - Earnings Call Transcript
(WorldNews Health)

ImmuCell Corporation (NASDAQ:ICCC) Q3 2018 Earnings Conference Call November 14, 2018 9:00 AM ET Executives Joe Diaz - Managing Partner, Lytham Partners, LLC Michael Brigham - President and Chief Executive Officer Analysts Kevin Ellich - Craig-Hallum Capital Group LLC Scott Billeadeau - Walrus Partners, LLC Sam Rebotsky - SER Asset Management Operator Good morning, and welcome to the ImmuCell Corporation Third Quarter 2018 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today´s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note that this event is being recorded. I´d now like to turn...